Mitochondria are essential organelles that harbor a reduced genome, and expression of that genome requires regulated metabolism of its transcriptome by nuclear-encoded proteins. Despite extensive investigation, a comprehensive map of the yeast mitochondrial transcriptome has not been developed and all of the RNA-metabolizing proteins have not been identified, both of which are prerequisites to elucidating the basic RNA biology of mitochondria. Here, we present a mitochondrial transcriptome map of the yeast S288C reference strain. Using RNAseq and bioinformatics, we show the expression level of all transcripts, revise all promoter, origin of replication, and tRNA annotations, and demonstrate for the first time the existence of alternative splicing, mirror RNAs, and a novel RNA processing site in yeast mitochondria. The transcriptome map has revealed new aspects of mitochondrial RNA biology and we expect it will serve as a valuable resource. As a complement to the map, we present our compilation of all known yeast nuclear-encoded ribonucleases (RNases), and a screen of this dataset for those that are imported into mitochondria. We sought to identify RNases that are refractory to recovery in traditional mitochondrial screens due to an essential function or eclipsed accumulation in another cellular compartment. Using this in silico approach, the essential RNase of the nuclear and cytoplasmic exosome, Dis3p, emerges as a strong candidate. Bioinformatics and in vivo analyses show that Dis3p has a conserved and functional mitochondrial-targeting signal (MTS). A clean and marker-less chromosomal deletion of the Dis3p MTS results in a defect in the decay of intron and mirror RNAs, thus revealing a role for Dis3p in mitochondrial RNA decay.
Citation: Turk EM, Das V, Seibert RD, Andrulis ED (2013) The Mitochondrial RNA Landscape of Saccharomyces cerevisiae. PLoS ONE8(10): e78105. https://doi.org/10.1371/journal.pone.0078105
Editor: Sander Granneman, Univ. of Edinburgh, United Kingdom
Received: February 15, 2013; Accepted: September 9, 2013; Published: October 15, 2013
Copyright: © 2013 Turk et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by a developmental biology training grant from the National Institutes of Health (T32HD007104) to E.M.T. and the National Institutes of General Medical Sciences (R01 GM0272820) to E.D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Competing interests: The authors have declared that no competing interests exist.
Mitochondrial inheritance was first discovered in 1949 in the yeast, Saccharomyces cerevisiae, by the group of Ephrussi and Slonimski (see 2 for a review). Yeast has since remained a model organism for the investigation of mitochondrial genetics. In 1996 the sequence of the16 nuclear chromosomes of wild-type yeast S288C[3,4] was released, and two years later the complete sequence of the mitochondrial genome of the same strain was published. The availability of a sequenced genome, and the subsequent creation of large-scale isogenic collections, such as the deletion of every open reading frame (ORF), has made S288C the cornerstone of contemporary yeast genetics. Recently, the entire nuclear transcriptome of S288C was presented in the seminal RNAseq publication; however, the mitochondrial transcriptome has not been sequenced.
The mitochondrial genome of S288C contains 35 genes required for oxidative phosphorylation. Polypeptides are encoded by 8 of those genes, which includes a ribosomal subunit (VAR1), cytochrome oxidase subunits I, II and III (COX1, COX2, COX3), apocytochrome b (COB), and three ATP synthase subunits (ATP6, APT8, ATP9). The other 27 genes encode RNAs required for translation of the 8 polypeptides, and they include 24 tRNAs, two ribosomal RNAs (21S rRNA and 15S rRNA) and the RNA subunit of RNase P (RPM1). The 21S rRNA gene contains an intron, COB contains five, and COX1 contains seven introns. All are group I or group II introns, which are mobile genetic elements that undergo protein-assisted, autocatalytic, RNA splicing[8,9]. There are also 11 ORFs that show sequence similarity to homing endonuclease genes (HEG). These ORFs have been shown in some cases to encode active homing endonuclease enzymes, and in other cases the protein appears to have lost DNase activity, or has gained maturase (intron splicing), or reverse transcriptase activity. Ten of the “HEG-related” ORFs are contained within group introns. The exception is Q0255, which is a HEG-related ORF that overlaps the 3’ end of the COX2 ORF, and is not associated with an intron.
Sequencing of the human mitochondrial transcriptome provided a recent example of the importance of post-transcriptional mechanisms to differential gene expression by showing differential abundance for mRNAs that originate from the same polycistronic transcript. An intensely studied mitochondrial post-transcriptional mechanism is RNA decay of the yeast and human degradosome. The degradosome was first discovered in yeast as a Suv3p-Dss1p complex with RNA helicase and 3’-5’ RNA exonuclease activity. The recently discovered human degradosome is analogous to the yeast degradosome, but consists of a hSuv3-PNPase complex. Suv3p is a conserved RNA helicase[15,16], while Dss1p and PNPase are the only known mitochondrial RNA decay ribonucleases.
Many RNA decay complexes contain 3’-5’ exoribonucleases, such as Rrp6p in the nuclear exosome, Dis3p of the nuclear and cytosolic exosome, PNPase of the bacterial degradosome, and the aforementioned PNPase and Dss1p of their respective human and yeast mitochondrial degradosome. PNPase is a phosphorolytic RNase PH-like exoribonuclease, while Rrp6p, Dss1p, and Dis3p are hydrolytic exoribonucleases of the RNase D, RNR (RNase II-like)[19,20], and RNase II/R family[21,22], respectively. Thus mode of action and homology are less important than the functional analogy of RNA decay in the 3’ to 5’ direction. Dss1p plays a significant role in mRNA surveillance and intron turnover in yeast mitochondria, but does not appear to be the only decay pathway in this system, because some RNAs have no change in level when DSS1 is genetically perturbed. In addition to Dss1p, Dis3p and Rrp6p, the yeast nuclear genome encodes many other 3’-5’ exoribonucleases, but does not encode PNPase. Thus it appears that a novel yeast mitochondrial ribonuclease remains to be identified.
Here we report an RNAseq analysis of highly purified mitochondria from the yeast S288C reference strain. This analysis advances our understanding of the identity, boundaries, splicing, cleavage, and quantities of mitochondrial RNAs. In addition, we report a comprehensive in silico search for yeast RNases and subsequent experiments that show Dis3p to be a mitochondrial protein involved in non-coding RNA (ncRNA) decay.
Materials and Methods
Yeast Strains and Growth Conditions
Yeast wild-type strain, BY4741 (ATCC #201388 http://www.atcc.org/), was obtained from Open Biosystems (https://www.openbiosystems.com) (Cat. #: YSC1048). BY4741 [MATa, his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0] is a haploid derivative of S288C. All other yeast strains used in this reports are derivatives of BY4741 (Table S1 in File S1).
Yeast cultures were initiated from frozen stocks by inoculation into 5 mL of YPD (1% yeast extract, 2% peptone, 2% dextrose) in a 14 mL round-bottom culture tube, followed by overnight incubation at 30°C and 245 rpm shaking. Over-night cultures were used to inoculate the experimental culture (1 L of YPD in a 4 L Belco baffle-bottom flask) to an OD600 of 0.5, followed by incubation at 30°C and 245 rpm for two days.
Four independent yeast cultures were grown for RNAseq analysis (two BY4741 and two dis3Δmts). Highly purified yeast mitochondria were isolated from ~10 g wet-weight of each culture according to published protocols. The sucrose-gradient purified mitochondria were treated with cyanase, a highly active and non-specific RNase/DNase, to mitigate cytoplasmic nucleic acid contamination. Mitochondria were re-purified and lysed in QIAzol from Qiagen. Total mitochondrial RNA was purified using the microRNeasy kit from Qiagen, with on column DNase treatment to remove mitochondrial genomic DNA.
All RNAseq (random sequencing of whole transcriptome) steps were performed by the genomic core facility at the Huntsman Cancer Institute including validation of RNA quality, quantity and purity; library preparation using the Illumina TruSeq Directional RNA protocol with fragmentation to reduce insert size to 30-300 bases, no DSN treatment, no polyA selection, no ribosomal or tRNA subtraction, and no size selection; and 101 cycle directional paired-end sequencing on an Illumina HiSeq2000 platform. Resulting sequence data was processed using Illumina's CASAVA software, version 1.7.0. to retain only high-quality reads, which were mapped with Bowtie using the Galaxy main instance[26-28]. Avadis NGS software was used to visualize and analyze mapped reads. Expression was measured in RPKM: # of reads mapped to a gene / (size of the transcript in kb) (total # of mappable reads in millions). P-values were calculated using the DESeq statistical method, which is based on the negative binomial distribution with variance and mean linked by local regression; n=2. When comparing the two DIS3 replicates to each other, or comparing the two dis3∆mts replicates to each other, there are no significant differences when the same gene is compared between two replicates.
Due to paired-end sequencing, two RNAseq datasets result from each RNA sample, a dataset of reads in the 5’-3’ direction and a dataset in the 3’-5’ direction, for a total of 8 datasets. Only the 5’-3’ datasets were used for this study to avoid the possibility of double-counting the expression of bases from inserts shorter than 202 bp. The 8 datasets have been deposited at the NCBI short read archive with the following accession numbers (5’-3’ dataset; 3’-5’ dataset). WT experiment-GCDA5 (SRR900222; SRR900223), WT experiment-GCDA8 (SRR900186; SRR900220), mutant experiment-N29dis3A5 (SRR900088; SRR900137), mutant experiment-N29dis3A8 (SRR900251; SRR900255).
RT-PCR and Sequencing of Alternative-Spliced aI5β
Gene-specific primers used to generate cDNA, amplify the alternative-spliced product, and sequence the resulting PCR product are described in Table S2 in File S1. SuperScriptTM III reverse transcriptase (Invitrogen) and the recommended protocol were used to synthesize cDNA from 50 ng of mitochondrial RNA from yeast strain BY4741, except the RNA was incubated with primers and dNTPs at 70°C for 5 min. Five units of RNase H (New England Biolabs) were used to digest the RNA complementary to the cDNA. The cDNA was then diluted 1:5 and 2 μL was used as a template for PCR. Immolase hot start DNA polymerase (Bioline) was used to amplify the spliced product with the following reaction conditions: 1x immobuffer, 3 mM MgCl2, 0.3 mM dNTP, 1 μM of forward and reverse primer, and 2.5 units of polymerase in a 50 μL reaction volume. The reaction was denatured at 95°C for 7 min, followed by 35 cycles of 95°C for 30s / 50°C for 30s / 72°C for 30s, and then 4°C hold. Reaction products were separated on a 1% agarose, 1X TAE horizontal gel, detected using ethidium bromide staining, and visualized with GeneSnap software (Syngene). A single 444 bp band was seen, which is the sized predicted for amplification of alternative-spliced aI5β. The PCR product was purified using the Qiaquick PCR purification kit (Qiagen), and then sequenced in both directions using the forward and reverse PCR primers, which resulted in 2-fold coverage over the splice junction.
Molecular Modeling and Mitochondrial Targeting Prediction
Full-length Dis3p and Arg8p were modeled using the I-TASSER web accessible program[30,31]. Prediction of mitochondrial targeting likelihood and targeting sequences was performed using the MitoProtII-v1.101 web-accessible program. The amino acid sequences used for both web programs were obtained from SGD.
Helical Wheel Projections
The N-terminus of Dis3p and Arg8p were assayed for the ability to form an amphipathic alpha helix using the Helical Wheel Projections program Version: Id: wheel.pl,v 1.4 2009-10-20 21:23:36 don Exp, created by Don Armstrong and Raphael Zidovetzki at the University of California Irvine. Web address: http://rzlab.ucr.edu/scripts/wheel/wheel.cgi. Dis3p has a 17 amino acid amphipathic alpha helix starting with lysine 11 (K11). Arg8p has a 15 amino acid amphipathic alpha helix starting with leucine 6 (L6). Hydrophilic residues are circles, hydrophobic residues are diamonds, potentially negatively charged are triangles, and potentially positively charged are pentagons. The most hydrophobic residue is green, and the amount of green is decreasing proportionally to the hydrophobicity, with zero hydrophobicity coded as yellow. Hydrophilic residues are coded red with pure red being the most hydrophilic (uncharged) residue, and the amount of red decreasing proportionally to the hydrophilicity. The potentially charged residues are light blue.
Functional Assay for Mitochondrial Matrix Localization
The ARG8 gene was cloned from yeast strain BY4741 into the low-copy pRS415 yeast shuttle vector. To facilitate manipulation of the MTS, the 3xFLAG coding sequence was inserted between the MTS and the rest of the ORF to generate pMTSARG8-ARG8. We also engineered a plasmid that contained no MTS coding sequence (pMTS∆-ARG8), or contained the MTS from DIS3 in place of the native MTS (pMTSDIS3-ARG8). Plasmids were transformed into an ARG8-deletion strain (arg8-∆0) that is isogenic to BY4741. Growth on arginine-free medium, which was scored after 3 days at 30°C, requires localization of Arg8p to the mitochondrial matrix. Plasmids and primers used in this experiment are described in Table S3 in File S1 and Table S4 in File S1 respectively.
Drosophila Cell Analysis
The complete 1001 amino acid sequence of S. cerevisiae Dis3p/Rrp44p was obtained from SGD and used as a blastp query (refseq_protein, fungi/metazoa, protein-protein, word size 3, BLOSUM62, existence 11, extension 1). The COBALT program was used to perform a multiple sequence alignment of the first 50 sequences.
Deletion of the DIS3 MTS
A novel homologous recombination strategy was used to insert the CUP1 promoter between the DIS3 promoter and ORF. This homologous recombination event simultaneously deleted the MTS (codons 2-29) and maintained expression of DIS3. The CUP1-containing cassette was then removed by a second homologous recombination event, resulting in a clean and marker-less deletion of the MTS to make strain dis3Δmts. Primers used for this experiment are described in Table S5 in File S1.
Gene-specific primers used to generate cDNA and amplify the target are described in Table S6 in File S1. The Bio-Rad iScript SYBR green kit 170-8893 and a Bio-Rad MyiQ2 machine was used for all RT-qPCR experiments. The manufacturer recommended cycle parameters and reaction conditions were followed exactly, including the use of 10 ng of RNA per 50 μL reaction and a final concentration of 300 nM for each primer. For each RNA investigated, RT-qPCR was performed 3 times for each of the 4 RNA samples (2 independent WT RNA samples and 2 independent dis3Δmts RNA samples) for a total of 12 experimental reactions plus a no-RT control for each individual RNA analyzed. In each case the resulting Ct values of the 6 WT reactions were compared to the 6 dis3Δmts reactions P-values were calculated using the Student’s t-test function built into Microsoft Excel (two tails, two samples equal).
Yeast Mitochondrial Transcriptome
To obtain sufficient quantities of total mitochondrial RNA for RNAseq analysis, we grew two independent cultures of yeast BY4741, a derivative of S288C, for two days in rich media. Within the fist day the cells completed the diauxic shift from fermentative growth on dextrose to aerobic growth on ethanol. During fermentative growth the cells divide rapidly and provide the abundant number of fresh cells required for mitochondrial isolation. Aerobic growth during the second day results in slow growing but mitochondrial-active cells. Highly purified mitochondrial RNA from each culture was subjected one time to Illumina Hiseq2000 deep sequencing, which resulted in approximately 9 million mapped reads for each RNA sample (~18 million total reads).
To create a reference for mapping RNAseq data, we built a model of the S288C mitochondrial genome using DNA sequence information from the Saccharomyces Genome Database (SGD; www.yeastgenome.org), the public repository for this organism . We annotated the genome using information from the SGD genome browser and the primary literature. Most of the experimental data in the literature is based on yeast strains D273-10B, KL14-A4, or W303, which were traditionally used for mitochondrial studies due to good respiratory growth, short mitochondrial genome, or availability, but which are not isogenic to S288C[24,38-40]. We therefore built a parsimonious map of the S288C mitochondrial transcriptome as a working model to be repeatedly tested and refined (Figure 1A).
(A) Physical, genetic, and transcriptome map of the yeast S288C mitochondrial genome. The positive strand is on the outside, and the negative is inside. The active ori (green arrows), inactive ori (grey arrows), primary transcripts (blue arrows), dodecamers (red lollipops), and deviant dodecamers (yellow lollipops) are modeled. The location of each gene is depicted using the systematic name, protein-coding genes are uppercase/bold, and the transcription start sites are numbered. To mark genes within introns, the intron is lowercase/first, “+”, and then the systematic name of the gene (B) The steady-state RNA abundance of all mitochondrial-encoded genes and introns measured in RPKM.
Mapping the RNAseq reads to our mitochondrial genomic annotation demonstrated clear differential expression of the 35 genes required for oxidative phosphorylation, the group introns, and the HEG-related ORFs (Figure 1B). Notably, there is also differential expression of genes that are on the same primary transcript. For example, the cluster of seven tRNAs on primary transcript starting at nucleotide 65,392 shows nearly 90-fold differential expression between the tRNA with the greatest RPKM (tRNA-Asp) and the tRNA with the least RPKM (tRNA-Arg). The order of genes on the primary transcript is related to the relative abundance in some cases. This is seen by the fact that the ATP9 gene is followed by tRNA-Ser and then VAR1 on the same transcript, and the order of abundance is also 5’ to 3’. These results are similar to the results obtained from sequencing the human mitochondrial transcriptome in that co-transcribed RNAs have differential abundance, which points to the importance of attenuated transcription between genes or post-transcriptional RNA processing/decay to provide differential gene expression[11,41].
Sequencing the mitochondrial transcriptome allowed us to determine for the first time the exact 3’ end of all 24 tRNAs. This is made possible by the presence of the non-encoded 3’ terminal CCA that is added post-transcriptionally to all tRNAs. Detection of the CCA addition site also allowed nucleotide-level resolution of the 5’ end of all tRNAs based on tRNA-structure prediction (Table 1). It is notable that the tRNAscan-SE algorithm[42,43] correctly identified 20 of the tRNAs—while primary reports collectively identified all 24—but correctly identified only 2 of the tRNA boundaries (Table 1).
|Systematic Name||tRNA Isotype||Strand||RNAseq tRNA Bounds||Mispredicted tRNA Bounds||tRNAscan-SE|
Promoters and Origin of Replication
To annotate the 5’ end of primary transcripts we analyzed the mitochondrial genomic sequence for the presence of the presumed 9-base yeast mitochondrial promoter, referred to as nonanucleotide[44,45]. We found that 11 promoters can account for expression of all mitochondrial genes and three promoters are associated with origins of replication (Table 2). Five other canonical nonanucleotide sequences also exist but they are not uniquely associated with a transcript (Table 3).
|Primary Transcripts||Promoter Nucleotides Not Part of the Nonanucleotide (Non-Template Strand)|
|COX1, ATP8, ATP6||A||T||T||G||A||T||A||G||A||T||A|
|ATP9, Ser2, VAR1||A||T||T||A||A||T||A||T||A||T||A|
|21S_rRNA, Thr, Cys, His||A||T||A||T||G||T||A||A||A||A||A|
|Leu, Gln, Lys, Arg, Gly, Asp, Ser, Arg2||T||G||T||T||A||T||A||A||T||A||T|
|Ala, Ile, Tyr, Asn, Met||T||T||T||A||T||A||T||A||A||T||A||T|
|Phe, Val, COX3||T||A||T||A||T||A||T||A||A||T||A||A|
|fMet, RPM1, Pro||G||A||T||T||T||A||T||A||T||A||A||T|
|Position of Promoter in Genome||Nucleotide Deviations From Consensus Promoter (Non-Template Strand)|
The yeast mitochondrial RNA polymerase is of phage T7 origin, but the nonanucleotide is considerably smaller than the 23-base phage T7 consensus promoter. We compared the sequences surrounding the minimal set of 14 promoters and derived a 20-base consensus sequence that is not found elsewhere in the mitochondrial genome. The five nonanucleotides that are not uniquely associated with a transcript also do not conform to the 20-base consensus promoter (Table 3). Thus, we conclude that phage T7 and native yeast mitochondrial promoter size is closely conserved, and the minimal set of promoters may also be the full-set.
Eight yeast mitochondrial origins of replication (ori) have been proposed, although not all of the ori are active, and those that are active are strain dependent. Our bioinformatic analysis of the S288C mitochondrial DNA sequence shows that 3 ori are immediately downstream of the 20-base promoter and conform to a 5-part consensus sequence (Figure 2A). Our RNAseq analysis shows that a contiguous transcript of greater than 350 nucleotides exists for each of the three presumably active ori, whereas the other 5 ori appear to be disabled by insertions within the promoter, and have few RNAseq reads associated with them. Each of the 5 presumably inactive ori contains a 35 bp insert at the identical site within the promoter (Figure 2B).
(A) Model based on the presumably active ori2-3-5, depicting the non-template strand. The structure consists of a 20-bp promoter (invariable length), followed by a 17-bp G-rich sequence (invariable length and sequence), then an A/T-rich spacer of ~200 bp, followed by two complementary 7-bp sequences (invariable length and sequence). The 7-bp sequences are separated by a 29-bp A/T-rich sequence (invariable length). (B) Alignment of the 20-bp promoters of the potentially active (2-3-5) and inactive (1-4-6-7-8) ori. Single nucleotide differences for ori3 and 4 are highlighted in red, and GC-elements that disrupt the promoter are in green.
Alternative Splicing, Start and Stop Codons
In human and yeast mitochondria, AUA codes for methionine[49,50] and can be utilized as an initiator codon. In yeast, only the aI5β intron-encoded maturase is thought to initiate with an AUA codon. All other yeast intron-encoded proteins are in-frame with their upstream exon and thus utilize AUG as the initiation codon. Strikingly, our RNAseq data shows that alternative splicing—the first identified in yeast mitochondria—puts aI5β in-frame with the upstream exon; thus all yeast mitochondrial proteins initiate with the AUG codon (Figure 3A). We confirmed this result by specifically amplifying the splice junction by RT-PCR followed by sequencing the product (Figure 3B). Additionally, this study confirms that all yeast mitochondrial ORFs utilize the UAA stop codon (Figure 4). Both the mechanism of mitochondrial alternative splicing, and the biological advantage of using a single stop codon, remain to be determined.
(A) Model of the 13 introns of yeast S288C mitochondria, and 10 HEG-related ORFs contained within them. The first five introns of COX1, and three COB introns, contain ORFs that are in-frame with their upstream exon. The ORF within the omega intron of 21S rRNA encodes an ATG at the 5’ end and a dodecamer at the 3’ end. The sixth intron of COX1, aI5β, contains an intron that is not in-frame with the upstream exon and does not encode an ATG at the 5’ end. (B) Electropherogram of the sequenced RT-PCR product derived from alternatively spliced aI5β. For comparison, the sequence derived from primary splicing or alternative splicing is depicted above the electropherogram. In both cases the 5’ exon is the sixth COX1 exon. The 3’ exon is the seventh COX1 exon in the case of primary splicing and the ORF within the aI5β intron in the case of alternative splicing.
Each gene is labeled using the standard name (www.yeastgenome.org) and convention (all capital, italic, no spaces), or the systematic name (all capital, regular) if no standard name is available. Each open reading frame begins with the AUG codon (green) and ends with the UAA stop codon (red). The size of the ORF in between the start and stop codons is depicted as number of bases, as is the distance in between the stop codon and the dodecamer (12 mer) sequence, which is blue with deviations bold/black. The likely cleavage sites are depicted with a down arrow. The BI3 and SCEI stop codons (bold/red) are within the dodecamer. The heptakaidecamer (17 mer) downstream of the ATP8 and BI3 dodecamer is underlined. The distance in between the OLI1 / ATP9 dodecamer and the downstream tRNA (Ser) that cleaves the primary transcript via normal tRNA processing is depicted as number of bases.
3’ RNA ends, Dodecamer, Heptakaidecamer, and Endonucleolytic Cleavage
It has been postulated that all yeast mitochondrial ORFs except ATP8 and ATP9 are processed at a dodecamer sequence in the 3’ untranslated region (UTR)[53,54]. The dodecamer directs endonucleolytic cleavage of the primary mRNA and protects the mature 3’ end from exonucleolytic decay. We have determined that ATP8 and ATP9 both have non-canonical dodecamer sequences, suggesting an alternative mechanism of mRNA cleavage (Figure 4). In this regard, ATP9 has a tRNA downstream of its dodecamer, and may undergo tRNA “punctuation,” that is, a mechanism of endonucleolytic cleavage of the 3’ end of primary transcripts in human and yeast mitochondria. We have also discovered a 17-base heptakaidecamer RNA cleavage site immediately downstream of the ATP8 dodecamer (Figure 4). Thus, non-canonical dodecamers may still provide protection to ATP8 and ATP9 mRNA 3’ ends, while cleavage has moved distally. In support of this, we also found a heptakaidecamer downstream of a deviant dodecamer at the end of the BI3 ORF (Figure 4).
Heptakaidecamer cleavage sites are particularly easy to identify in our RNAseq data because numerous reads end precisely at the 5’ cleavage nucleotide, and numerous other reads begin precisely at the 3’ cleavage nucleotide. The heptakaidecamer is found 18 times in the S288C mitochondrial genome, but in our RNAseq dataset we only find reads associated with the RNA ends of four of them (Figure 5A).
(A) Alignment of four heptakaidecamer sequences. The down arrow that separates the blue and the orange sequences indicates the cleavage site. (B) The non-template strand of the 483-bp, unprocessed, RNA subunit of RNase P, derived from the mitochondrial-encoded RPM1 gene. Boxes represent the three fragments identified in purified RNase P. Fragment 1 (89 nt) is at the 5’ end of the primary transcript, and fragments 2 (71 nt) and #3 (52 nt) overlap and are positioned at the 3’ end. The 5’ fragment is separated from the 3’ fragments by a heptakaidecamer cleavage site highlighted in blue and orange. The base immediately upstream and downstream of cleavage is underlined.
In addition to the two aforementioned heptakaidecamer sequences, we find a cleavage site ~3kb downstream of the end of the 15S rRNA / Trp transcript, and a fourth cleavage site within the RPM1 transcript (Figure 5B). This discovery is significant because mature yeast mitochondrial RNase P contains three fragments of RPM1 but no full-length RPM1. The heptakaidecamer separates the fragments from the primary transcript. Yeast RNase P is thus analogous to the cytoplasmic ribosome in that both are built from primary RNAs that are cleaved and processed into smaller RNAs that then assemble with proteins to operate on RNA substrates.
Dis3p is a Mitochondrial Protein
Mitochondrial RNA decay—first identified in yeast as the biological function of the Dss1p-Suv3p degradosome—is a regulatory mechanism of mitochondrial gene expression. Humans share the Suv3p helicase but lack a recognizable Dss1p homolog. The human RNase partner is PNPase[14,57], although the degradosome may not be the sole RNA decay machinery in yeast or human cells. Perhaps mitochondrial RNases have evaded detection due to redundancy, null lethality, transient localization, minute accumulation, or eclipsed distribution.
To identify elusive mitochondrial RNases, we scored every putative yeast RNase for null lethality, localization, and percent likelihood of mitochondrial targeting (Table 4, 5, 6, 7). Dis3p emerged as a strong candidate for a conserved mitochondrial RNase. Dis3p, an exo- and endo-RNase component of the exosome, is responsible for numerous RNA metabolic functions in the nucleus and cytoplasm. In support of the bioinformatic findings, four independent proteomic studies found Dis3p in highly purified mitochondria[60-63] (Table 8). One of these studies identified a Dis3p N-terminal peptide that was processed at a canonical matrix-cleavage site. Further support for Dis3p being mitochondrial comes from proteomic screens, where Dis3p co-purifies with Mas1p, the matrix protease that cleaves the N-terminal MTS from imported proteins[64,65] (Table 8). Notably, although Dis3p stably interacts with the 9-subunit exosome core, no core exosome subunits were identified in the mitochondrial proteome[60-63].
|Standard Name||Systematic Name||Alias||Family||Reported Localization||Description||Null||Human Homolog||MitoProtII score (cs)|
|DIS3||YOL021C||RRP4 4MTR17||E.coli RNase R of RNase II PIN||Nuclear Cytoplasmic Mitochondrial||Exosome RNA decay and processing||Lethal||DIS3 DIS3L DIS3L2||96.3 (30)|
|NUC1||YJL208C||Nuclear Mitochondrial||Apoptosis||Viable||EndoG||7.4 (NP)|
|Standard Name||Systematic Name||Alias||Family||Reported Localization||Description||Null||Human Homolog||MitoProtII score (cs)|
|PET127||YOR017W||Mitochondrial||May not have RNase activity Mitochondrial RNA 5’-end processing||Viable||None||98.0 (48)|
|RAT1||YOR048C||HKE1 TAP1 XRN2||Nuclear Mitochondrial||Nuclear, single-stranded RNase rRNA and snRNA processing poly (A+) dependent and independent mRNA transcription termination||Lethal||XRN2||94.4 (18)|
|RRP17||YDR412W||Cytoplasmic||rRNA processing||Lethal||NOL12/NOP25||84.5 (NP)|
|XRN1||YGL173C||KEM1 DST2 RAR5 SEP1 SKI1||Cytoplasmic||Cytoplasmic processing (P) bodies involved in mRNA decay||Viable||XRN1||56.9 (18)|
|Standard Name||Systematic Name||Alias||Family||Reported Localization||Description||Null||Human Homolog||MitoProtII score (cs)|
|DSS1||YMR287C||MSU1||RNase II||Mitochondrial||Degradosome||Viable||None||99.7 (35)|
|REX2||YLR059C||YNT20||RNase D||Mitochondrial||Mitochondrial genome maintenance snRNA 3’-end processing||Viable||REXO2||99.1 (33)|
|REX4||YOL080C||Nuclear||pre-rRNA processing||Viable||None||96.6 (55)|
|YME2||YMR302C||RNA12 PRP12||Mitochondrial||Mitochondrial genome maintenance||Viable||None||93.3 (45)|
|RRP6||YOR001W||DEDD||RNase D||Nuclear nuclear exosome||Viable||EXOSC10||35.4 (NP)|
|REX3||YLR107W||RNase D||Nuclear Cytoplasmic||3’-end processing of ncRNA, rRNA, snRNA||Viable||None||30.6 (NP)|
|PAN3||YKL025C||Cytoplasmic||Pan2p-Pan3p deadenylation||Viable||21.2 (NP)|
|NGL3||YML118W||Exo- Endo-Phosphatase (EEP)||Unknown||specific for poly-A RNAs||Viable||None||17.1 (NP)|
|POP2||YNR052C||CAF1||DEDD||Cytoplasmic||3’ to 5’ mRNA deadenylation Ccr4-NOT complex||Viable||CNOT7||10.5 (19)|
|RNH70||YGR276C||REX1 RNA82||RNase H RNase D||Nuclear||maturation of 3’ ends of 5S rRNA and tRNA-Arg3||Viable||ZFP42||3.7 (NP)|
|PAN2||YGL094C||ECM35||Cytoplasmic||Pan2p-Pan3p deadenylation||Viable||hPAN2||2.3 (NP)|
|CCR4||YAL021C||FUN27 NUT21||Exo- Endo-Phosphatase (EEP)||Cytoplasmic||3’ to 5’ mRNA deadenylation Ccr4-NOT complex||Viable||CNOT6||0.0 (NP)|
|Standard Name||Systematic Name||Alias||Family||Reported Localization||Description||Null||Human Homolog||MitoProtII score (cs)|
|IRE1||YHR079C||ERN1||RNase L||Nuclear||HAC1 mRNA splicing||Viable||ERN1||97.6 (45)|
|NGL1||YOL042W||Exo- endo-Phosphatase (EEP)||Mitochondrial||5.8S rRNA processing at site E||Viable||LRRC4C||96.3 (24)|
|DBR1||YKL149C||PRP26||Nuclear||Lariate Debranching||Viable||DBR1||40.1 (NP)|
|NOB1||YOR056C||PINc domain||Nuclear Cytoplasmic||rRNA processing||Lethal||ART 4||31.9 (NP)|
|NMD4||YLR363C||PINc domain||Cytoplasmic||No RNase Activity Shown||Viable||None||20.5 (NP)|
|RNY1||YPL123C||T2 RNase||Cytoplasmic Vacuolar||cleaves tRNA||Viable||None||17.6 (NP)|
|SEN34||YAR008W||FUN4||Cytoplasmic-OMM (Outer MitoMem)||tRNA 3’ splice site cleavage||Lethal||TSEN34 LENG5||4.1 (NP)|
|DOM34||YNL001W||Cytoplasmic||No-Go mRNA Decay||Viable||None||3.9 (NP)|
|NGL2||YMR285C||Exo- endo-Phosphatase (EEP)||Nuclear||5.8S rRNA processing||Viable||None||3.4 (NP)|
|SEN2||YLR105C||Cytoplasmic-OMM (Outer MitoMem)||tRNA 5' splice site cleavage||Lethal||TSEN2||3.3 (NP)|
|SWT1||YOR166C||PIN domain||Nuclear Cytoplasmic||perinuclear mRNP quality control||Viable||None||3.2 (NP)|
|TRZ1||YKR079C||tRNase Z metallo-β-lactamase||Nuclear Cytoplasmic Mitochondrial||tRNA 3'-end processing endonuclease||Lethal||ELAC2||2.7 (NP)|
|RNT1||YMR239C||RNAase III||Nuclear||rRNA, snRNA processing||Viable||None||1.3 (NP)|
|YSH1||YLR277C||BRR5||metallo-β-lactamase||Nuclear||3' processing of mRNAs||Lethal||CPSF2||0.7 (NP)|
|RPR1||Nuclear||ncRNA nuclear RNase P; cleaves 5' ends of tRNA precursors||Lethal||RPPH1 H1 RNA|
|RPM1||9S RNA||Mitochondrial||ncRNA mitochondrial RNase P, removes 5' extensions from mitochondrial tRNA precursors||Viable||None Protein-only|
|NME1||RRP2||Nuclear Cytoplasmic||snoRNA RNase MRP, cleaves pre-rRNA||Lethal||RMRP|
|Group I introns||Self-Splicing||Mitochondrial||RNA component of Mito Introns||Viable|
|Group II introns||Self-Splicing||Mitochondrial||RNA component of Mito Introns||Viable|
|2009||Cell||Vogtle et al||N-terminal sequencing. Dis3p cleaved pre-sequence is 26aa long, ends with R, and the first amino acid of the mature protein is S (processed mitochondrial proteins typically cleave between R and S).||Sucrose or YPG|
|2006||Journal of Proteomic Research||Reinders et al||Dis3p peptide fingerprint||YPG|
|2006||Nature||Gavin et al||Mas1p Physical Interaction||YPD|
|2004||PLOS Biology||Prokisch et al||Dis3p peptide fingerprint||SCD or YPD|
|2003||PNAS||Sickmann et al||Dis3p peptide fingerprint||YPG|
|2002||Nature||Gavin et al||Mas1p Physical Interaction||YPD|
To determine whether the Dis3p N-terminus is part of the tertiary structure or available to function as a signal peptide, we used I-TASSER[30,31] to comparatively model the protein structure of Dis3p to that of Arg8p, a mitochondrial matrix protein required for arginine biosynthesis. Dis3p crystal structures are available, but an ordered N-terminus has only been reported in the context of the exosome, and in this case it forms a β–hairpin when wedged between Rrp41-Rrp42 [66,67]. We chose Arg8p to use as a comparative model because this would also serve to inform our design of a reporter system (see next paragraph). The models indicate that both proteins have an available N-terminal peptide (Figure 6A). Helical wheel analysis of Dis3p and Arg8p show that each N-terminal peptide forms an amphipathic alpha helix, the basic structure of most mitochondrial import signals (Figure 6B).
(A) I-TASSER models of Dis3p and Arg8p. N-termini indicated by arrows. (B) Amphipathic alpha helix located at the N-terminus of Dis3p and Arg8p. Single letter amino acid code and position in the primary structure is indicated. (C) Growth of yeast on arginine-free medium when the MTS of DIS3 replaces the plasmid borne MTS of ARG8. (D) The Drosophila dDis3 N-terminus can function as an MTS for GFP, but mutation of the MTS (4A) cannot. (E) Western blot of cell fractionation. C (cytoplasm), M (mitochondria).
To assess protein import to the mitochondrial matrix in vivo, we created a reporter system in which plasmid-borne ARG8 rescues loss of arginine-prototrophic growth of an ARG8-deletion strain. Removal of the ARG8 plasmid-borne MTS eliminates the growth rescue, whereas replacement with the DIS3 MTS restores growth (Figure 6C). To assess conservation of Dis3p mitochondrial localization, we appended the DIS3 MTS from Drosophila melanogaster to GFP followed by expression in fly S2 cell culture. Fluorescence is detected in mitochondria and lost when DIS3 MTS is absent or mutagenized (Figure 6D). Cell fractionation also shows native Dis3p in S2 mitochondria (Figure 6E). Bioinformatic alignment of 50 Dis3p homologs confirms the conservation of the N-terminus (Figure 7). Thus Dis3p appears to be a genuine mitochondrial protein.
DIS3 is Involved in Mitochondrial RNA Decay
To determine the biological significance of the MTS, we engineered an allele in which DIS3 codons 2-29 were deleted from the yeast genome (Figure 8). DIS3 is an essential gene and thus cannot be deleted unless compensated by plasmid-borne DIS3. Changing the genomic context could alter endogenous expression so rather than use a plasmid-based system; we created a chromosomal mutant of DIS3 in which only the MTS is deleted. The protein resulting from the dis3∆mts allele is expected to be mitochondrial excluded. Yeast strains harboring the dis3∆mts allele are not growth impaired on fermentable or non-fermentable carbon sources, suggesting a redundant function. This is consistent with truncation experiments in S. pombe in which the N-terminal 74 amino acids of Dis3p were determined not to be essential. To investigate the contribution of Dis3p to mitochondrial RNA metabolism, we performed replicate RNAseq analyses on RNA extracted from purified DIS3 and dis3∆mts mitochondria. For DIS3 mitochondria, we found 71% coverage of the positive strand and 25% coverage of the negative strand. We also found a 9% increase in the base coverage for both the positive and negative strand in dis3∆mts, suggesting that Dis3p has a role in modulating the abundance of RNAs that would otherwise be too unstable to detect, much like the role of the exosome in nuclear RNA surveillance. This coverage contrasts with the human mitochondrial transcriptome, which has ~98% of both strands transcribed. Whereas in that study, ~1.4 million uniquely mapping reads provided saturation of coverage, we obtained ~36 million uniquely mapping reads.
(A) Amplified the CORE molecule by PCR from plasmid pGSKU using primers 9H9 / 9H10, which include targeting sequences at their 5‘ ends. (B) Amplified the upstream targeting molecule by PCR from yeast chromosomal DNA, strain BY4741, using primers 9C7 / 9F3. Amplified the downstream targeting molecule by PCR from yeast chromosomal DNA, strain PCUP1-DIS3 which is a derivative of BY4741, using primers 9I1 / 8G9. (C) Simultaneously transformed the three molecules into BY4741. (D) Transformation resulted in a strain in which the MTS is deleted, DIS3 is expressed by the CUP1 promoter, and identical self-cloning sites (SCS) flank the cassette. (E) Over-night growth in galactose media induced expression of SCE1 endonuclease, which cleaved the DNA at the restriction site (RS), and the cut was repaired by homologous recombination between the SCS, which removed the cassette. The entire gene was amplified by PCR using primers 9E10 / 9F1 and sequenced with the PCR primers and internal primers 8G8, 9C8, and 9D3.
There is no difference in steady-state levels of mRNAs, with the exception of ATP9, which is ~2-fold increased in dis3∆mts (Figure 9A). We find that most tRNA and mRNA genes have corresponding antisense transcripts, which are analogous to so-called “mirror” RNA in human mitochondria. In the dis3∆mts mitochondria, notably, some of these RNAs accumulate (Figure 9B,C). We also found a striking increase in the accumulation of some group intron RNAs of the COB gene when Dis3p is mitochondrial excluded (Figure 10A). We confirmed by RT-qPCR the hyper-accumulation of RNA derived from introns bI1–thru-4. Importantly, we saw no change in the abundance of COB ligated exons or control RNAs (Figure 10B). As the degradosome is the only known protein complex to decay mitochondrial intron RNA, it remains to be determined if Dis3p interacts directly with these RNAs, in concert with or independent of Suv3p and Dss1p.
Wild type (DIS3) reads are first / blue and the mutant (dis3∆mts) are second / green. Error bars = s.e.m. Asterisk denotes a statistically significant difference with a p-value less than 0.01 as determined by the DESeq statistical method. (A) Read count in RPKM for the eight mRNAs that encode proteins required for oxidative phosphorylation. (B) Total number of reads that map to each mirror ORF. (C) Total number of reads that map to each mirror tRNA.
(A) Fold change of the RPKM value between DIS3 and dis3∆mts for the exons and introns of 21S rRNA, COX1, and COB. Values >1 indicate an increase in reads in dis3∆mts. Only the first and last exon (orange) of each intron-containing gene is shown for purposes of clarity. Error bars = s.e.m. Asterisk denotes a statistically significant difference with a p-value less than 0.01 as determined by the DESeq statistical method. (B) RT-qPCR of DIS3 and dis3∆mts RNA. Change in Ct value for the first exon of 21S rRNA (orange), the first and last exon of COB (orange), the five COB introns (blue), and ligated exons (LE / green) of the COB gene. Values greater than zero indicate greater abundance in dis3∆mts. Error bars = s.e.m. Asterisk denotes a statistically significant difference with a p-value less than 0.01 as determined by the Student’s t-test.
Bioinformatic Construction of the S288C Mitochondrial Transcriptome
We have assembled a mitochondrial transcriptome map for the yeast S288C reference strain. In this context a transcriptome map is basically a “parts list” of all the RNAs of a system, and a description of their boundaries, their physical location on the genome, and their abundance. Building a map is a step towards elucidating how all of the parts of the mitochondria act in concert to precisely balance the energy needs of the cell. This overarching goal cannot be accomplished without first characterizing the parts themselves.
To date no transcriptome map has been built for any yeast strain. We chose to use yeast S288C because of the numerous scientific resources associated with this strain. However, an enormous body of mitochondrial RNA literature has accumulated around a few yeast strains that are not isogenic to S288C. We therefore used the primary literature in conjunction with the sequenced S288C mitochondrial genome to build a parsimonious transcriptome map. This provides a model for the iterative work of testing and refinement.
We modeled the identity and 5’ boundary of all primary transcripts by identifying the minimal number of promoters to account for transcription of all known mitochondrial genes and active ori. Although twenty-eight potential yeast mitochondrial promoters, centered on the nonanucleotide sequence, have been reported [72,73], we only used the minimal number of promoters. This was done to avoid the inclusion of promoters that are reported to be active in vitro [73-77] or in another yeast strain[44,45,78-80], but which may not be active in S288C.
In addition to setting the minimal number of transcripts to 14, our results also expand the established size of the promoter from 9 to 20 base pairs. This is significant because modulation of transcription initiation is a known response to changes in mitochondrial function. The initiating nucleotide of the yeast mitochondrial promoter is always adenosine in vivo, despite observed activity when changed to any other nucleotide in vitro. The use of ATP to make the first nucleotide of the transcript has likely been evolutionarily conserved because it provides a benefit to the cell as an ATP sensor. Our bioinformatic analysis has increased the sequence space that is potentially part of the regulatory apparatus, and, due to the conservation we see, there are likely to be other parts of the promoter that provide a cellular benefit.
We modeled the 3’ end of each primary transcript by searching the mitochondrial genomic sequence for dodecamer or tRNA sequences because there is no known transcriptional terminator or polyadenylation in yeast mitochondria. The RNA polymerase transcribes beyond the dodecamers and terminal tRNAs and is released by an unknown mechanism. The 3’ end is formed by cleavage 2 bp downstream of the dodecamer in the case of ORFs or via endonucleolytic processing of a tRNA. The presence of the dodecamer likely provides protection from decay for mRNA, while the rRNA and tRNA are protected by their secondary structures, but the stabilizing mechanism for these RNAs is unknown.
A complete transcriptome map includes the ori because an RNA that is derived de novo from a nonanucleotide-containing promoter primes DNA synthesis[81,82]. To our knowledge, ori2, 3, and 5 are the only oris that have been shown to be active in every report in which they have been tested. The other five oris have been shown to be inactive or only active in some strains. We thus built a model of the S288C mitochondrial ori based on ori2, 3, and 5.
We found the consensus ori to fit nicely the current model, which begins with a promoter followed by a G-rich sequence, an AT spacer, and then GC-AT-GC rich sequences that likely fold into a hairpin. The G-rich sequence is 4 bp downstream of the 20-bp consensus promoter for ori2, but overlaps with the last 4 bp of the ori3 and ori5 promoters. Thus, we find the spacing between the end of the promoter and the start of the G-rich sequence to have some flexibility. We compared the promoters of the other five ori and found that each has an insert that would likely disrupt transcription initiation, and, hence, render the ori inactive. The mechanism by which the same promoter is used for the dual roles of DNA synthesis and regulated transcription initiation remains to be identified, but may involve cis-acting elements outside of the promoter.
RNAseq Analysis of the S288C Mitochondrial Transcriptome
The primary purpose of our RNAseq analysis was to quantify RNA abundance, and, as such, we did not optimize for the detection of transcription start sites (TSS), RNA 3’ ends, or active ori. Such optimization would have required rRNA and tRNA subtraction to get deep coverage of TSS, which in some cases are unstable. For example, those TSS that are followed by a tRNA are undetectable in our RNAseq data. This is likely due to the fact that tRNA are removed from their primary transcripts by endonucleolytic cleavage, and there is no known stabilizing sequence between the TSS and the tRNA cleavage site. Thus the freed 5’ RNA would likely be a strong substrate for RNA decay. We also did not attempt to detect RNA-DNA hybrid molecules, which would be necessary to authenticate the active ori. Our RNAseq data is consistent with our model of TSS, RNA 3’ ends, and ori, but further experimental validation is required.
We precisely mapped the 3’ terminal nucleotide of all 24 mitochondrial-encoded tRNA due to the presence of non-encoded CCA trinucleotide. Simultaneously identifying the boundaries and measuring the quantities of all tRNA should provide a valuable tool to investigate tRNA metabolic pathways. Mitochondrial tRNA is processed by endonucleolytic cleavage at the 5’ and 3’ end by RNase P and RNase Z respectively, but most molecular components of the processing, modifying, surveillance, stability, and decay complexes have not been identified.
Yeast mitochondrial RNA abundance has been measured numerous times, but with various strains, techniques and standards, and only on a limited number of RNAs. We choose an RNAseq approach because it allows us to simultaneously measure the abundance of all mRNA, rRNA, tRNA, and other ncRNA. This gives us the ability to refine our transcriptome map, and allows us to identify proteins that are involved in mitochondrial RNA metabolism by comparing all RNAs in mutant to wild-type yeast. This prevents the exclusion of proteins that only work on a subset of RNAs.
The utility of measuring all RNAs simultaneously can be seen in the example of Var1p, a ribosomal protein that was recently shown to be a negative regulator of mitochondrial DNA maintenance. During conditions of enhanced mitochondrial need the cell could potentially benefit from negative regulation of Var1p activity. When yeast is grown in conditions that require enhanced mitochondrial activity, we find that VAR1 has the lowest RNA abundance of any mitochondrial gene (Figure 9A). It is tempting to speculate that one mechanism of regulating Var1p activity is through modulating protein abundance via mRNA abundance.
Previous studies have suggested that differential yeast mitochondrial RNA abundance depends upon rates of transcription initiation, transcription termination/attenuation, RNA processing, and RNA decay. VAR1 is co-transcribed with ATP9, but opposed to Var1p, enhanced Atp9p activity would be valuable to the cell during a time of enhanced mitochondrial activity. In fact, ATP9 is ~20-fold greater in RNA abundance over VAR1 in the conditions we tested. Further work will be required to determine if transcription is attenuated after the RNA polymerase passes the ATP9 ORF—as is the case for the co-transcribed Glu - COB genes—or if the difference in RNA abundance is due to a post-transcriptional mechanism. We conclude that our transcriptome map is a valuable tool for elucidating the interconnected processes of genome maintenance and gene expression.
Dis3p an Active Participant in Mitochondrial Intron Decay?
Dis3p associates with a 9-subunit core ring structure (Exo-9) in the cytoplasm of S. cerevisiae to form an exosome that contributes to the processing and turnover of numerous cellular RNAs[68,91,92]. Dis3p is the only component of the cytoplasmic exosome with RNase activity, being a 3’-5’ hydrolytic exonuclease[93,94] and having a PIN domain required for endonucleolytic activity[59,95-97]. Dis3p and Exo-9 are also present in the nucleus, where they associate with the Rrp6 RNase to form an exosome involved in RNA surveillance[98-101].
Our bioinformatic analysis of all yeast RNases identified Dis3p as a candidate for mitochondrial localization. Although numerous proteomic studies show Dis3p in mitochondria, the same studies do not find other components of the exosome within the mitochondria[60-65]. There is precedence for Dis3p acting independent of the exosome[97,101-103]. For example, Dis3p can bind and degrade RNA in vitro in the absence of any other proteins[22,93,94,97,104]. Thus Dis3p may be a mitochondrial RNase that acts independent of the core.
RNAseq analysis of the dis3∆mts strain shows significantly more bI2, 3, and 4 intron RNA than in the wild type. Due to greater variability in the results for bI1, the difference did not reach our stringent threshold of significance. However, RT-qPCR confirmed the RNAseq results and showed a significant hyper-accumulation of bI1 intron RNA. Hyper-accumulation of intron RNA can be due to enhanced transcription of the primary transcript, which could be detected as an accumulation in the amount of the first exon. Accumulation of intron RNA could also result from a defect in splicing, as un-spliced RNA is often more stable than freed intron RNA, and this can be scored as a decrease in the accumulation of ligated exons. We found no difference in the abundance of exons or ligated exons and thus the hyper-accumulated introns are not a result of aberrant transcription or splicing. Hyper-accumulation of intron RNA in dis3∆mts is likely due to a defect in RNA decay, which is consistent with Dis3p endo- and exo-ribonuclease activity. However, this study has not addressed if Dis3p interacts directly with any of these RNAs, or if ribonuclease activity is required for these effects.
We could find nothing in common among the four affected introns that would suggest a reason for their hyper-accumulation in the mutant, while bI5 and all other introns are largely unaffected. A somewhat similar phenomenon was found for the aI5β and bI3 introns, in that the suv3-1 allele specifically affects the splicing of these two introns, due to a defect in degradosome-promoted decay of excised intron RNA. These two group I introns belong to different subclasses and do not share significant sequence homology. It was determined that the common factor responsible for the RNA-decay defect was Mrs1p, which is required for the splicing of both introns[107,108]. It is likely that Mrs1p must be removed from excised intron RNA before decay can occur, but this is blocked in the suv3-1 background, which causes a defect in recycling of Mrs1p and hence a block in splicing. Thus there may be a protein, or a structure in common with the bI1-4 RNAs, and Dis3p may act in concert with, or upstream of the degradosome to generate “degradosome-friendly” substrates via RNA binding, exonuclease, or endonuclease activities. Dis3p may also promote the decay of other RNAs, but the affect is masked in our experiments by redundancy with another protein.
It is a formal possibility that un-importable Dis3p could indirectly affect mitochondrial RNA decay by degrading cytoplasmic SUV3 or DSS1 transcripts, thereby depleting mitochondrial Suv3p or Dss1p. However, we consider this unlikely because the most dramatic defect of SUV3 or DSS1 perturbation is massive accumulation of the omega intron RNA—and there is no change in the abundance of this RNA in the dis3∆mts strain (Figure 10A). We favor the more parsimonious explanation: yeast Dis3p directly mediates mitochondrial RNA decay similar to its roles in the nucleus and cytoplasm. This interpretation is in keeping with the current exozyme hypothesis, in which Dis3p is predicted to have some exosome-independent functions. Further work will be required to determine if authentic untagged Dis3p localizes to the matrix, if Dis3p interacts directly with mitochondrial RNA, and if RNA decay depends on Dis3p ribonuclease and RNA binding activities.
We present here the first yeast mitochondrial RNAseq study and the first demonstration of mitochondrial Dis3p. Molecular components of RNA processing, stability, and decay complexes still remain to be identified, and we have begun to address this by excluding individual proteins from the mitochondrion, and then measuring the abundance of all RNA species. In addition to DIS3, other candidates have been identified and excluding them individually and in tandem may uncover novel or redundant functions. By discovering the individual components we will be able to address the systems objective of understanding how all of the working parts of the mitochondrion coordinate to provide the energy balance that is crucial to life.
File includes Tables S1-S6.
Table S1 Yeast strains used in this study.
Table S2 Primers used to sequence aI5β alternative-spliced junction.
Table S3 Plasmids used in the functional assay for mitochondrial matrix localization.
Table S4 Primers used in the functional assay for mitochondrial matrix localization.
Table S5 Primers used in yeast fly mutagenesis experiments.
Table S6 Primers used in RT-qPCR.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conceived and designed the experiments: EMT RS VD EDA. Performed the experiments: EMT RS VD EDA. Analyzed the data: EMT RS VD EDA. Contributed reagents/materials/analysis tools: EMT EDA. Wrote the manuscript: EMT. Edited the manuscript: EDA.
- 1. Ephrussi B (1949) Action de l’acriflavine sur les levures. In: Unités Biologiques Douées de Continuité Génétiqué. du Paris: Centre Nat Rech Sci: 165-180.
- 2. Hagemann R (2010) The foundation of extranuclear inheritance: plastid and mitochondrial genetics. Mol Genet Genomics 283: 199-209. doi:10.1007/s00438-010-0521-z. PubMed: 20140454.
- 3. Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B et al. (1996) Life with 6000 genes. Science 274: 546: 563-547. PubMed: 8849441.
- 4. Goffeau A, Aert R, Agostini-Carbone ML, Ahmed A, Aigle M (1997) The yeast genome directory. Nature 387: 5. doi:10.1038/387005b0. PubMed: 9169864.
- 5. Foury F, Roganti T, Lecrenier N, Purnelle B (1998) The complete sequence of the mitochondrial genome of Saccharomyces cerevisiae. FEBS Lett 440: 325-331. doi:10.1016/S0014-5793(98)01467-7. PubMed: 9872396.
- 6. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901-906. doi:10.1126/science.285.5429.901. PubMed: 10436161.
- 7. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D et al. (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320: 1344-1349. doi:10.1126/science.1158441. PubMed: 18451266.
- 8. Lambowitz AM, Zimmerly S (2004) Mobile group II introns. Annu Rev Genet 38: 1-35. doi:10.1146/annurev.genet.38.072902.091600. PubMed: 15568970.
- 9. Lang BF, Laforest MJ, Burger G (2007) Mitochondrial introns: a critical view. Trends Genet 23: 119-125. doi:10.1016/j.tig.2007.01.006. PubMed: 17280737.
- 10. Belfort M, Roberts RJ (1997) Homing endonucleases: keeping the house in order. Nucleic Acids Res 25: 3379-3388. doi:10.1093/nar/25.17.3379. PubMed: 9254693.
- 11. Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA et al. (2011) The human mitochondrial transcriptome. Cell 146: 645-658. doi:10.1016/j.cell.2011.06.051. PubMed: 21854988.
- 12. Szczesny RJ, Borowski LS, Malecki M, Wojcik MA, Stepien PP et al. (2012) RNA degradation in yeast and human mitochondria. Biochim Biophys Acta 1819: 1027-1034. doi:10.1016/j.bbagrm.2011.11.010. PubMed: 22178375.
- 13. Dziembowski A, Piwowarski J, Hoser R, Minczuk M, Dmochowska A et al. (2003) The yeast mitochondrial degradosome. Its composition, interplay between RNA helicase and RNase activities and the role in mitochondrial RNA metabolism. J Biol Chem 278: 1603-1611. doi:10.1074/jbc.M208287200. PubMed: 12426313.
- 14. Borowski LS, Dziembowski A, Hejnowicz MS, Stepien PP, Szczesny RJ (2013) Human mitochondrial RNA decay mediated by PNPase-hSuv3 complex takes place in distinct foci. Nucleic Acids Res 41: 1223-1240. doi:10.1093/nar/gks1130. PubMed: 23221631.
- 15. Szczesny RJ, Borowski LS, Brzezniak LK, Dmochowska A, Gewartowski K et al. (2010) Human mitochondrial RNA turnover caught in flagranti: involvement of hSuv3p helicase in RNA surveillance. Nucleic Acids Res 38: 279-298. doi:10.1093/nar/gkp903. PubMed: 19864255.
- 16. Szczesny RJ, Wojcik MA, Borowski LS, Szewczyk MJ, Skrok MM et al. (2013) Yeast and human mitochondrial helicases. Biochim Biophys Acta 1829: 842-853. doi:10.1016/j.bbagrm.2013.02.009. PubMed: 23454114.
- 17. Hardwick SW, Gubbey T, Hug I, Jenal U, Luisi BF (2012) Crystal structure of Caulobacter crescentus polynucleotide phosphorylase reveals a mechanism of RNA substrate channelling and RNA degradosome assembly. Open Biol 2: 120028. doi:10.1098/rsob.120028. PubMed: 22724061.
- 18. Midtgaard SF, Assenholt J, Jonstrup AT, Van LB, Jensen TH et al. (2006) Structure of the nuclear exosome component Rrp6p reveals an interplay between the active site and the HRDC domain. Proc Natl Acad Sci U S A 103: 11898-11903. doi:10.1073/pnas.0604731103. PubMed: 16882719.
- 19. Dziembowski A, Malewicz M, Minczuk M, Golik P, Dmochowska A et al. (1998) The yeast nuclear gene DSS1, which codes for a putative RNase II, is necessary for the function of the mitochondrial degradosome in processing and turnover of RNA. Mol Gen Genet 260: 108-114. doi:10.1007/s004380050876. PubMed: 9829834.
- 20. Zuo Y, Vincent HA, Zhang J, Wang Y, Deutscher MP et al. (2006) Structural basis for processivity and single-strand specificity of RNase II. Mol Cell 24: 149-156. doi:10.1016/j.molcel.2006.09.004. PubMed: 16996291.
- 21. Wang HW, Wang J, Ding F, Callahan K, Bratkowski MA et al. (2007) Architecture of the yeast Rrp44 exosome complex suggests routes of RNA recruitment for 3' end processing. Proc Natl Acad Sci U S A 104: 16844-16849. doi:10.1073/pnas.0705526104. PubMed: 17942686.
- 22. Lorentzen E, Basquin J, Tomecki R, Dziembowski A, Conti E (2008) Structure of the active subunit of the yeast exosome core, Rrp44: diverse modes of substrate recruitment in the RNase II nuclease family. Mol Cell 29: 717-728. doi:10.1016/j.molcel.2008.02.018. PubMed: 18374646.
- 23. Wang G, Shimada E, Koehler CM, Teitell MA (2012) PNPASE and RNA trafficking into mitochondria. Biochim Biophys Acta 1819: 998-1007. doi:10.1016/j.bbagrm.2011.10.001. PubMed: 22023881.
- 24. Brachmann CB, Davies A, Cost GJ, Caputo E, Li J et al. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 115-132. doi:10.1002/(SICI)1097-0061(19980130)14:2. PubMed: 9483801.
- 25. Meisinger C, Pfanner N, Truscott KN (2006) Isolation of yeast mitochondria. Methods Mol Biol 313: 33-39. PubMed: 16118422.
- 26. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L et al. (2005) Galaxy: a platform for interactive large-scale genome analysis. Genome Res 15: 1451-1455. doi:10.1101/gr.4086505. PubMed: 16169926.
- 27. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R et al. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol Chapter 19: Unit 19.10.1: Unit 19 10 11-21 PubMed: 20069535.
- 28. Goecks J, Nekrutenko A, Taylor J, Galaxy T (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11: R86. doi:10.1186/gb-2010-11-8-r86. PubMed: 20738864.
- 29. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106. doi:10.1186/gb-2010-11-10-r106. PubMed: 20979621.
- 30. Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40. doi:10.1186/1471-2105-9-40. PubMed: 18215316.
- 31. Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725-738. doi:10.1038/nprot.2010.5. PubMed: 20360767.
- 32. Claros MG, Vincens P (1996) Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur J Biochem 241: 779-786. doi:10.1111/j.1432-1033.1996.00779.x. PubMed: 8944766.
- 33. Christianson TW, Sikorski RS, Dante M, Shero JH, Hieter P (1992) Multifunctional yeast high-copy-number shuttle vectors. Gene 110: 119-122. doi:10.1016/0378-1119(92)90454-W. PubMed: 1544568.
- 34. Graham AC, Kiss DL, Andrulis ED (2009) Core exosome-independent roles for Rrp6 in cell cycle progression. Mol Cell Biol 20: 2242-2253. doi:10.1091/mbc.E08-08-0825. PubMed: 19225159.
- 35. Hirschman JE, Balakrishnan R, Christie KR, Costanzo MC, Dwight SS et al. (2006) Genome Snapshot: a new resource at the Saccharomyces Genome Database (SGD) presenting an overview of the Saccharomyces cerevisiae genome. Nucleic Acids Res 34: D442-D445. doi:10.1093/nar/gkj117. PubMed: 16381907.
- 36. Fisk DG, Ball CA, Dolinski K, Engel SR, Hong EL et al. (2006) Saccharomyces cerevisiae S288C genome annotation: a working hypothesis. Yeast 23: 857-865. doi:10.1002/yea.1400. PubMed: 17001629.
- 37. Bernardi G (2005) Lessons from a small, dispensable genome: the mitochondrial genome of yeast. Gene 354: 189-200. doi:10.1016/j.gene.2005.03.024. PubMed: 15978748.
- 38. Wolf K, Dujon B, Slonimski PP (1973) Mitochondrial genetics. V. Multifactorial mitochondrial crosses involving a mutation conferring paromomycin-resistance in Saccharomyces cerevisiae. Mol Gen Genet 125: 53-90. doi:10.1007/BF00292983. PubMed: 4590264.
- 39. Van Ommen GJ, Groot GS, Grivell LA (1979) Transcription maps of mtDNAs of two strains of saccharomyces: transcription of strain-specific insertions; Complex RNA maturation and splicing. Cell 18: 511-523. doi:10.1016/0092-8674(79)90068-0. PubMed: 227609.
- 40. Mortimer RK, Johnston JR (1986) Genealogy of principal strains of the yeast genetic stock center. Genetics 113: 35-43. PubMed: 3519363.
- 41. Krause K, Dieckmann CL (2004) Analysis of transcription asymmetries along the tRNAE-COB operon: evidence for transcription attenuation and rapid RNA degradation between coding sequences. Nucleic Acids Res 32: 6276-6283. doi:10.1093/nar/gkh966. PubMed: 15576354.
- 42. Lowe TM, Eddy SR (1997) tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res 25: 955-964. doi:10.1093/nar/25.5.955. PubMed: 9023104.
- 43. Chan PP, Lowe TM (2009) GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res 37: D93-D97. doi:10.1093/nar/gkn787. PubMed: 18984615.
- 44. Osinga KA, De Haan M, Christianson T, Tabak HF (1982) A nonanucleotide sequence involved in promotion of ribosomal RNA synthesis and RNA priming of DNA replication in yeast mitochondria. Nucleic Acids Res 10: 7993-8006. doi:10.1093/nar/10.24.7993. PubMed: 6298705.
- 45. Osinga KA, Tabak HF (1982) Initiation of transcription of genes for mitochondrial ribosomal RNA in yeast: comparison of the nucleotide sequence around the 5'-ends of both genes reveals a homologous stretch of 17 nucleotides. Nucleic Acids Res 10: 3617-3626. doi:10.1093/nar/10.12.3617. PubMed: 6287415.
- 46. Masters BS, Stohl LL, Clayton DA (1987) Yeast mitochondrial RNA polymerase is homologous to those encoded by bacteriophages T3 and T7. Cell 51: 89-99. doi:10.1016/S0006-3495(87)83314-3. PubMed: 3308116.
- 47. Dunn JJ, Studier FW (1983) Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. J Mol Biol 166: 477-535. doi:10.1016/S0022-2836(83)80282-4. PubMed: 6864790.
- 48. Faugeron-Fonty G, Le Van Kim C, de Zamaroczy M, Goursot R, Bernardi G (1984) A comparative study of the ori sequences from the mitochondrial genomes of twenty wild-type yeast strains. Gene 32: 459-473. doi:10.1016/0378-1119(84)90020-9. PubMed: 6397407.
- 49. Barrell BG, Bankier AT, Drouin J (1979) A different genetic code in human mitochondria. Nature 282: 189-194. doi:10.1038/282189a0. PubMed: 226894.
- 50. Hudspeth ME, Ainley WM, Shumard DS, Butow RA, Grossman LI (1982) Location and structure of the var1 gene on yeast mitochondrial DNA: nucleotide sequence of the 40.0 allele. Cell 30: 617-626. doi:10.1016/0092-8674(82)90258-6. PubMed: 6754087.
- 51. Folley LS, Fox TD (1991) Site-directed mutagenesis of a Saccharomyces cerevisiae mitochondrial translation initiation codon. Genetics 129: 659-668. PubMed: 1661254.
- 52. Hensgens LA, Bonen L, de Haan M, van der Horst G, Grivell LA (1983) Two intron sequences in yeast mitochondrial COX1 gene: homology among URF-containing introns and strain-dependent variation in flanking exons. Cell 32: 379-389. doi:10.1016/0092-8674(83)90457-9. PubMed: 6297792.
- 53. Osinga KA, De Vries E, Van der Horst G, Tabak HF (1984) Processing of yeast mitochondrial messenger RNAs at a conserved dodecamer sequence. EMBO J 3: 829-834. PubMed: 6327291.
- 54. Hofmann TJ, Min J, Zassenhaus HP (1993) Formation of the 3' end of yeast mitochondrial mRNAs occurs by site-specific cleavage two bases downstream of a conserved dodecamer sequence. Yeast 9: 1319-1330. doi:10.1002/yea.320091205. PubMed: 7512302.
- 55. Ojala D, Montoya J, Attardi G (1981) tRNA punctuation model of RNA processing in human mitochondria. Nature 290: 470-474. doi:10.1038/290470a0. PubMed: 7219536.
- 56. Daoud R, Forget L, Lang BF (2012) Yeast mitochondrial RNase P, RNase Z and the RNA degradosome are part of a stable supercomplex. Nucleic Acids Res 40: 1728-1736.
- 57. Chujo T, Ohira T, Sakaguchi Y, Goshima N, Nomura N et al. (2012) LRPPRC/SLIRP suppresses PNPase-mediated mRNA decay and promotes polyadenylation in human mitochondria. Nucleic Acids Res, 40: 8033–47. PubMed: 22661577.
- 58. Regev-Rudzki N, Pines O (2007) Eclipsed distribution: a phenomenon of dual targeting of protein and its significance. Bioessays 29: 772-782. doi:10.1002/bies.20609. PubMed: 17621655.
- 59. Lebreton A, Tomecki R, Dziembowski A, Séraphin B (2008) Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature 456: 993-996. doi:10.1038/nature07480. PubMed: 19060886.
- 60. Sickmann A, Reinders J, Wagner Y, Joppich C, Zahedi R et al. (2003) The proteome of Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci U S A 100: 13207-13212. doi:10.1073/pnas.2135385100. PubMed: 14576278.
- 61. Prokisch H, Scharfe C, Camp DG 2nd, Xiao W, David L et al. (2004) Integrative analysis of the mitochondrial proteome in yeast. PLOS Biol 2: e160. doi:10.1371/journal.pbio.0020160. PubMed: 15208715.
- 62. Reinders J, Zahedi RP, Pfanner N, Meisinger C, Sickmann A (2006) Toward the complete yeast mitochondrial proteome: multidimensional separation techniques for mitochondrial proteomics. J Proteome Res 5: 1543-1554. doi:10.1021/pr050477f. PubMed: 16823961.
- 63. Vögtle FN, Wortelkamp S, Zahedi RP, Becker D, Leidhold C et al. (2009) Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell 139: 428-439. doi:10.1016/j.cell.2009.07.045. PubMed: 19837041.
- 64. Gavin AC, Bösche M, Krause R, Grandi P, Marzioch M et al. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415: 141-147. doi:10.1038/415141a. PubMed: 11805826.
- 65. Gavin AC, Aloy P, Grandi P, Krause R, Boesche M et al. (2006) Proteome survey reveals modularity of the yeast cell machinery. Nature 440: 631-636. doi:10.1038/nature04532. PubMed: 16429126.
- 66. Makino DL, Baumgärtner M, Conti E (2013) Crystal structure of an RNA-bound 11-subunit eukaryotic exosome complex. Nature 495: 70-75. doi:10.1038/nature11870. PubMed: 23376952.
- 67. Bonneau F, Basquin J, Ebert J, Lorentzen E, Conti E (2009) The yeast exosome functions as a macromolecular cage to channel RNA substrates for degradation. Cell 139: 547-559. doi:10.1016/j.cell.2009.08.042. PubMed: 19879841.
- 68. Mitchell P, Petfalski E, Shevchenko A, Mann M, Tollervey D (1997) The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'-->5' exoribonucleases. Cell 91: 457-466. doi:10.1016/S0092-8674(00)80432-8. PubMed: 9390555.
- 69. Kinoshita N, Goebl M, Yanagida M (1991) The fission yeast dis3+ gene encodes a 110-kDa essential protein implicated in mitotic control. Mol Cell Biol 11: 5839-5847. PubMed: 1944266.
- 70. Houseley J, Tollervey D (2008) The nuclear RNA surveillance machinery: the link between ncRNAs and genome structure in budding yeast? Biochim Biophys Acta 1779: 239-246. doi:10.1016/j.bbagrm.2007.12.008. PubMed: 18211833.
- 71. Turk EM, Caprara MG (2010) Splicing of yeast aI5beta group I intron requires SUV3 to recycle MRS1 via mitochondrial degradosome-promoted decay of excised intron ribonucleoprotein (RNP). J Biol Chem 285: 8585-8594. doi:10.1074/jbc.M109.090761. PubMed: 20064926.
- 72. Deshpande AP, Patel SS (2012) Mechanism of transcription initiation by the yeast mitochondrial RNA polymerase. Biochim Biophys Acta 1819: 930-938. doi:10.1016/j.bbagrm.2012.02.003. PubMed: 22353467.
- 73. Biswas TK (1998) Usage of non-canonical promoter sequence by the yeast mitochondrial RNA polymerase. Gene 212: 305-314. doi:10.1016/S0378-1119(98)00133-4. PubMed: 9611272.
- 74. Biswas TK, Ticho B, Getz GS (1987) In vitro characterization of the yeast mitochondrial promoter using single-base substitution mutants. J Biol Chem 262: 13690-13696. PubMed: 3308881.
- 75. Biswas TK (1990) Control of mitochondrial gene expression in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 87: 9338-9342. doi:10.1073/pnas.87.23.9338. PubMed: 2251275.
- 76. Biswas TK (1999) Nucleotide sequences surrounding the nonanucleotide promoter motif influence the activity of yeast mitochondrial promoter. Biochemistry 38: 9693-9703. doi:10.1021/bi982804l. PubMed: 10423248.
- 77. Amiott EA, Jaehning JA (2006) Mitochondrial transcription is regulated via an ATP "sensing" mechanism that couples RNA abundance to respiration. Mol Cell 22: 329-338. doi:10.1016/j.molcel.2006.03.031. PubMed: 16678105.
- 78. Christianson T, Rabinowitz M (1983) Identification of multiple transcriptional initiation sites on the yeast mitochondrial genome by in vitro capping with guanylyltransferase. J Biol Chem 258: 14025-14033. PubMed: 6315717.
- 79. Bordonné R, Dirheimer G, Martin RP (1987) Transcription initiation and RNA processing of a yeast mitochondrial tRNA gene cluster. Nucleic Acids Res 15: 7381-7394. doi:10.1093/nar/15.18.7381. PubMed: 3309893.
- 80. Biswas TK (1996) Expression of the mitochondrial RNase P RNA subunit-encoding gene from a variant promoter sequence in Saccharomyces cerevisiae. Gene 170: 23-30. doi:10.1016/0378-1119(95)00874-8. PubMed: 8621084.
- 81. Baldacci G, Chérif-Zahar B, Bernardi G (1984) The initiation of DNA replication in the mitochondrial genome of yeast. EMBO J 3: 2115-2120. PubMed: 6092055.
- 82. Graves T, Dante M, Eisenhour L, Christianson TW (1998) Precise mapping and characterization of the RNA primers of DNA replication for a yeast hypersuppressive petite by in vitro capping with guanylyltransferase. Nucleic Acids Res 26: 1309-1316. doi:10.1093/nar/26.5.1309. PubMed: 9469842.
- 83. Baldacci G, Bernardi G (1982) Replication origins are associated with transcription initiation sequences in the mitochondrial genome of yeast. EMBO J 1: 987-994. PubMed: 6329719.
- 84. de Zamaroczy M, Marotta R, Faugeron-Fonty G, Goursot R, Mangin M et al. (1981) The origins of replication of the yeast mitochondrial genome and the phenomenon of suppressivity. Nature 292: 75-78. doi:10.1038/292075a0. PubMed: 7024821.
- 85. Tracy RL, Stern DB (1995) Mitochondrial transcription initiation: promoter structures and RNA polymerases. Curr Genet 28: 205-216. doi:10.1007/BF00309779. PubMed: 8529266.
- 86. Rossmanith W (2012) Of P and Z: mitochondrial tRNA processing enzymes. Biochim Biophys Acta 1819: 1017-1026. doi:10.1016/j.bbagrm.2011.11.003. PubMed: 22137969.
- 87. Mueller DM, Getz GS (1986) Steady state analysis of mitochondrial RNA after growth of yeast Saccharomyces cerevisiae under catabolite repression and derepression. J Biol Chem 261: 11816-11822. PubMed: 2427512.
- 88. Litvinchuk AV, Sokolov SS, Rogov AG, Markova OV, Knorre DA et al. (2013) Mitochondrially-encoded protein Var1 promotes loss of respiratory function in Saccharomyces cerevisiae under stressful conditions. Eur J Cell Biol 92: 169-174. doi:10.1016/j.ejcb.2013.02.001. PubMed: 23523087.
- 89. Markov DA, Savkina M, Anikin M, Del Campo M, Ecker K et al. (2009) Identification of proteins associated with the yeast mitochondrial RNA polymerase by tandem affinity purification. Yeast 26: 423-440. doi:10.1002/yea.1672. PubMed: 19536766.
- 90. Mueller DM, Getz GS (1986) Transcriptional regulation of the mitochondrial genome of yeast Saccharomyces cerevisiae. J Biol Chem 261: 11756-11764. PubMed: 3528145.
- 91. Houseley J, LaCava J, Tollervey D (2006) RNA-quality control by the exosome. Nat Rev Mol Cell Biol 7: 529-539. doi:10.1038/nrm1964. PubMed: 16829983.
- 92. Schaeffer D, Clark A, Klauer AA, Tsanova B, van Hoof A (2011) Functions of the cytoplasmic exosome. Adv Exp Med Biol 702: 79-90. PubMed: 21713679.
- 93. Dziembowski A, Lorentzen E, Conti E, Séraphin B (2007) A single subunit, Dis3, is essentially responsible for yeast exosome core activity. Nat Struct Mol Biol 14: 15-22. doi:10.1038/nsmb1184. PubMed: 17173052.
- 94. Mamolen M, Andrulis ED (2009) Characterization of the Drosophila melanogaster Dis3 ribonuclease. Biochem Biophys Res Commun 390: 529-534. doi:10.1016/j.bbrc.2009.09.132. PubMed: 19800864.
- 95. Schaeffer D, Tsanova B, Barbas A, Reis FP, Dastidar EG et al. (2009) The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities. Nat Struct Mol Biol 16: 56-62. doi:10.1038/nsmb.1528. PubMed: 19060898.
- 96. Schneider C, Leung E, Brown J, Tollervey D (2009) The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome. Nucleic Acids Res 37: 1127-1140. PubMed: 19129231.
- 97. Mamolen M, Smith A, Andrulis ED (2010) Drosophila melanogaster Dis3 N-terminal domains are required for ribonuclease activities, nuclear localization and exosome interactions. Nucleic Acids Res 38: 5507-5517. doi:10.1093/nar/gkq295. PubMed: 20421210.
- 98. Briggs MW, Burkard KT, Butler JS (1998) Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S rRNA 3' end formation. J Biol Chem 273: 13255-13263. doi:10.1074/jbc.273.21.13255. PubMed: 9582370.
- 99. Houseley J, Tollervey D (2009) The many pathways of RNA degradation. Cell 136: 763-776. doi:10.1016/j.cell.2009.01.019. PubMed: 19239894.
- 100. Lykke-Andersen S, Brodersen DE, Jensen TH (2009) Origins and activities of the eukaryotic exosome. J Cell Sci 122: 1487-1494. doi:10.1242/jcs.047399. PubMed: 19420235.
- 101. Graham AC, Davis SM, Andrulis ED (2009) Interdependent nucleocytoplasmic trafficking and interactions of Dis3 with Rrp6, the core exosome and importin-alpha3. Traffic 10: 499-513. doi:10.1111/j.1600-0854.2009.00888.x. PubMed: 19220816.
- 102. Schneider C, Anderson JT, Tollervey D (2007) The exosome subunit Rrp44 plays a direct role in RNA substrate recognition. Mol Cell 27: 324-331. doi:10.1128/MCB.01394-06. PubMed: 17643380.
- 103. Malecki M, Viegas SC, Carneiro T, Golik P, Dressaire C et al. (2013) The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway. EMBO J 32: 1842-1854. doi:10.1038/emboj.2013.63. PubMed: 23503588.
- 104. Liu Q, Greimann JC, Lima CD (2006) Reconstitution, activities, and structure of the eukaryotic RNA exosome. Cell 127: 1223-1237. doi:10.1016/j.cell.2006.10.037. PubMed: 17174896.
- 105. Conrad-Webb H, Perlman PS, Zhu H, Butow RA (1990) The nuclear SUV3-1 mutation affects a variety of post-transcriptional processes in yeast mitochondria. Nucleic Acids Res 18: 1369-1376. doi:10.1093/nar/18.6.1369. PubMed: 2158076.
- 106. Michel F, Westhof E (1990) Modelling of the three-dimensional architecture of group I catalytic introns based on comparative sequence analysis. J Mol Biol 216: 585-610. doi:10.1016/0022-2836(90)90386-Z. PubMed: 2258934.
- 107. Kreike J, Schulze M, Pillar T, Körte A, Rödel G (1986) Cloning of a nuclear gene MRS1 involved in the excision of a single group I intron (bI3) from the mitochondrial COB transcript in S. cerevisiae. Curr Genet 11: 185-191. doi:10.1007/BF00420605. PubMed: 2834089.
- 108. Bousquet I, Dujardin G, Poyton RO, Slonimski PP (1990) Two group I mitochondrial introns in the cob-box and coxI genes require the same MRS1/PET157 nuclear gene product for splicing. Curr Genet 18: 117-124. doi:10.1007/BF00312599. PubMed: 1699677.
- 109. Zhu H, Conrad-Webb H, Liao XS, Perlman PS, Butow RA (1989) Functional expression of a yeast mitochondrial intron-encoded protein requires RNA processing at a conserved dodecamer sequence at the 3' end of the gene. Mol Cell Biol 9: 1507-1512. PubMed: 2657398.
- 110. Kiss DL, Andrulis ED (2011) The exozyme model: a continuum of functionally distinct complexes. RNA 17: 1-13. doi:10.1261/rna.2364811. PubMed: 21068185.